Screener
iRadimed IRMD Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: iRadimed’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029325
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Accrued income taxes | 3,902 | 1,814 |
| Total current liabilities | 12,118 | 10,180 |
| Deferred revenue, non-current | 3,757 | 3,978 |
| Total liabilities | $15,875 | 14,158 |
| Stockholders’ equity: | ||
| Common stock; $0.0001 par value per share; 31,500,000 shares authorized; 12,782,837 shares issued and outstanding as of March 31, 2026, and 12,781,774 shares issued and outstanding as of December 31, 2025 | $1 | $1 |
| Additional paid-in capital | 31,020 | 30,386 |
| Retained earnings | 67,493 | 64,231 |
Item 1. Condensed Financial Statements
FAQ
- What is iRadimed's total liabilities?
- iRadimed (IRMD) reported total liabilities of $15.88M in Q1 2026.
- How has iRadimed's total liabilities changed year-over-year?
- iRadimed's total liabilities increased by 36.0% year-over-year, from $11.68M to $15.88M.
- What is the long-term trend for iRadimed's total liabilities?
- Over 5 years (2020 to 2025), iRadimed's total liabilities has grown at a 7.9% compound annual growth rate (CAGR), from $9.68M to $14.16M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about iRadimed's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude